PEMBROLIZUMAB vs PEMIGATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PEMBROLIZUMAB vs PEMIGATINIB: Safety Overview
| Metric | PEMBROLIZUMAB | PEMIGATINIB |
|---|---|---|
| Total FAERS Reports | 83,779 | 709 |
| Deaths Reported | 15,543 | 121 |
| Death Rate | 18.6% | 17.1% |
| Hospitalizations | 35,472 | 185 |
| Average Patient Age | 64.1 yrs | 54.0 yrs |
| % Female Patients | 49.9% | 56.2% |
| FDA Approval Date | N/A | Apr 17, 2020 |
| Manufacturer | Merck Sharp & Dohme LLC | Incyte Corporation |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Prescription |